Резултати

eNauka >  Results >  Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).
Title: Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).
Authors: Goel, Shom; O'Shaughnessy, Joyce; Tan, Antoinette R; Milev-Krastev, Boris; Rugo, Hope S; Aftimos, Philippe Georges; Yardley, Denise A; Andric, Zoran G  ; Wolfgang, Curt Douglas; Sorrentino, Jessica;
Tao, Wenli; Beelen, Andrew Paul; Malik, Rajesh K; Jain, Sarika;
Issue Date: 2021
Publication: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 39 br. 15 str. TPS1107-TPS1107
DOI: 10.1200/JCO.2021.39.15_suppl.TPS1107
WoS-ID: 000708120306161
URI: https://enauka.gov.rs/handle/123456789/823243
Project: G1 Therapeutics, Inc
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
OpenCitations
2
WEB OF SCIENCETM
Алт метрика
Dimensions
Unpaywall

Google ScholarTM

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.